GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Redwood Pharma AB (OSTO:REDW) » Definitions » Gross-Profit-to-Asset %

Redwood Pharma AB (OSTO:REDW) Gross-Profit-to-Asset % : 0.00% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Redwood Pharma AB Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Redwood Pharma AB's annualized Gross Profit for the quarter that ended in Mar. 2024 was kr0.00 Mil. Redwood Pharma AB's average Total Assets over the quarter that ended in Mar. 2024 was kr14.52 Mil. Therefore, Redwood Pharma AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 0.00%.


Redwood Pharma AB Gross-Profit-to-Asset % Historical Data

The historical data trend for Redwood Pharma AB's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redwood Pharma AB Gross-Profit-to-Asset % Chart

Redwood Pharma AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross-Profit-to-Asset %
Get a 7-Day Free Trial - - - - -

Redwood Pharma AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Redwood Pharma AB's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Redwood Pharma AB's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Redwood Pharma AB's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Redwood Pharma AB's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Redwood Pharma AB's Gross-Profit-to-Asset % falls into.



Redwood Pharma AB Gross-Profit-to-Asset % Calculation

Redwood Pharma AB's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2022 )/( (Total Assets (A: Dec. 2021 )+Total Assets (A: Dec. 2022 ))/ count )
=0/( (21.217+18.217)/ 2 )
=0/19.717
=0.00 %

Redwood Pharma AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=0/( (17.373+11.676)/ 2 )
=0/14.5245
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Redwood Pharma AB Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Redwood Pharma AB's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Redwood Pharma AB Business Description

Traded in Other Exchanges
Address
Ringvagen 100E, 9th Floor, Stockholm, SWE, 118 60
Redwood Pharma AB is engaged in developing new ophthalmic pharmaceutical therapies for unmet market needs. Its development product is a new therapy to treat chronic Dry Eye Disease (DED) in post-menopausal women.

Redwood Pharma AB Headlines

No Headlines